Browse the evidence

Higher plasma adiponectin levels are positively associated with greater insulin-stimulated glucose utilization (M) in adult women, independent of age, while adiponectin levels are negatively associated with visceral and subcutaneous abdominal fat.

For adult women, maintaining lower abdominal fat (visceral and subcutaneous) is associated with higher levels of adiponectin, a hormone that improves how your body uses glucose. While age itself does not lower adiponectin, the accumulation of abdominal fat often does. Focusing on reducing abdominal fat and improving insulin sensitivity may support healthier adiponectin levels.

A low-fat dietary intervention (reducing fat intake to 15% of calories) improves recurrence-free survival and overall survival in breast cancer survivors, particularly those with hormone-receptor-negative disease or without hot flushes.

For breast cancer survivors, reducing dietary fat to around 15% of total calories may improve survival outcomes, especially if you do not have hot flushes. This should be done through structured counseling and regular monitoring, not just self-guided changes. Focus on reducing fat intake specifically, as simply eating more fruits and vegetables without reducing fat did not show the same benefits.

Six months of resistance training improves absolute glucose disposal in nonobese young women primarily through increased fat-free mass (mass effect) without altering intrinsic muscle insulin sensitivity.

If you are a young, healthy woman, doing resistance training three times a week for six months will improve your body's ability to manage blood sugar. This happens because you are building more muscle mass, which acts as a larger sink for glucose, rather than by losing fat. You do not need to lose weight to see this metabolic benefit.

Six months of endurance training improves intrinsic muscle insulin sensitivity (glucose disposal per unit of fat-free mass) in nonobese young women, independent of changes in body composition or aerobic capacity.

If you are a young, healthy woman, doing endurance exercise three times a week for six months will improve your muscles' ability to use glucose. This happens because the exercise changes how the muscle itself processes sugar, not because you lost weight or got fitter in terms of VO2 max. You do not need to lose fat to get this specific metabolic benefit.

Favorable inflammatory status (lower C3, CRP, IL-6, TNF-α, PAI-1, and WBC; higher adiponectin) is positively associated with metabolically healthy obesity (MHO) and metabolically healthy nonobese (MHNO) phenotypes, distinguishing them from metabolically unhealthy counterparts regardless of BMI.

If you are obese, your health risk is not automatically high. Your body's inflammatory markers (like CRP and IL-6) and hormones (like adiponectin) play a crucial role. Getting these tested can help distinguish between 'metabolically healthy obesity' and 'metabolically unhealthy obesity,' guiding whether you need aggressive intervention or just monitoring. Focus on reducing inflammation through lifestyle, as it may be a key lever for metabolic health independent of weight loss.

Pharmacological activation of the AMPK pathway using agents such as metformin or AICAR improves glucose homeostasis and insulin sensitivity in type 2 diabetes models.

If you are at high risk for type 2 diabetes, lifestyle changes are the most effective first step. However, if lifestyle changes alone are not enough, metformin is a proven medication that can significantly reduce your risk of developing diabetes.

High levels of proinflammatory cytokines TWEAK and TNF-α are associated with an increased risk of sarcopenia, while metabolic hormones IGF1, insulin, and adiponectin are associated with a decreased risk.

If you are over 60, getting your blood checked for inflammatory markers like TWEAK and TNF-α, and metabolic hormones like IGF1 and insulin, might provide a clearer picture of your muscle health risk than just looking at weight. High levels of these markers are linked to a much higher risk of sarcopenia. However, the good news is that lifestyle changes, specifically resistance training and whey protein supplementation, can significantly lower these inflammatory markers and improve muscle mass.

Activation of Toll-like receptors 2 and 4 (TLR2/4) by saturated fatty acids and endotoxins drives chronic low-grade inflammation and insulin resistance in obesity and metabolic syndrome.

Focus on reducing saturated fat intake and improving gut health to lower the triggers (endotoxins/FFAs) that activate inflammatory receptors (TLRs). This can help reduce the chronic inflammation that drives insulin resistance.

Frequent loud snoring significantly predicts the development of metabolic syndrome in community-dwelling adults, independent of the Apnea-Hypopnea Index (AHI).

If you frequently snore loudly, it is not just a sleep issue; it is a specific risk factor for developing metabolic syndrome. You should discuss this symptom with your healthcare provider, as it may indicate a need for metabolic screening even if you do not have other diagnosed sleep disorders.

Difficulty falling asleep (DFA) and unrefreshing sleep are significant predictors of metabolic syndrome development, independent of loud snoring and AHI.

Pay attention to how long it takes you to fall asleep and whether you feel rested. These specific sleep quality issues are linked to a higher risk of metabolic syndrome. Addressing these symptoms with a healthcare provider may help mitigate this risk.

Extending the dose-escalation period or temporarily suspending dose increases when gastrointestinal adverse events occur improves tolerability and treatment persistence without compromising long-term efficacy.

If you feel sick after a dose increase, don't rush to the next one. Stay at the current dose for a few extra weeks or pause until you feel better. This helps your body adjust and keeps you on the medication longer.

Pharmacological management of persistent nausea with domperidone (preferred over metoclopramide) or other anti-emetics/prokinetics is an effective strategy for managing GLP-1 RA-induced nausea when dietary and titration strategies fail.

If diet changes aren't enough, ask your doctor about domperidone. It is often preferred over other anti-nausea drugs because it has fewer serious side effects. Use it as needed for nausea.

In elderly men, lower relative skeletal muscle mass (RASM) is associated with narrower bones, thinner cortices, and decreased bending strength (section modulus), as well as impaired balance and an increased risk of falls.

For older men, maintaining muscle mass is crucial for bone strength and balance. Focus on resistance training to preserve muscle, as this supports bone geometry (width and cortical thickness) and reduces fall risk, even if bone density measurements alone don't tell the whole story.

Menopausal hormone therapy (MHT), specifically estrogen, initiated in women aged 60 or younger or within 10 years of menopause, significantly reduces coronary heart disease and all-cause mortality.

If you are a healthy woman under 60 or within 10 years of menopause, discuss estrogen therapy with your doctor. It may reduce your risk of heart disease and death, contrary to older general warnings. This benefit does not apply if you are older than 60 or many years past menopause.

Menopausal hormone therapy (MHT) reduces the risk of developing type 2 diabetes and improves diabetes control, primarily by reducing central adiposity and increasing insulin sensitivity.

MHT may help prevent type 2 diabetes in postmenopausal women by improving insulin sensitivity and reducing abdominal fat. However, this benefit only lasts while you are taking the therapy.

Menopausal hormone therapy (MHT) prevents osteoporosis-related fractures when initiated in the 'window of opportunity' (before age 60 or within 10 years of menopause).

If you are a healthy woman under 60 or within 10 years of menopause, MHT (specifically CEE 0.625 mg daily) is effective for preventing bone fractures. Ensure you also get enough calcium and Vitamin D and do weight-bearing exercise.

Moderate-intensity, high-volume resistance training significantly improves insulin sensitivity in nonobese NIDDM patients without altering maximal oxygen uptake (VO2max).

If you have type 2 diabetes and are not obese, performing resistance training 5 days a week for 4-6 weeks using moderate weights with higher repetitions (10-20 reps) can significantly improve how your body handles insulin. You do not need to lose weight or improve your cardiovascular endurance (VO2max) to see these metabolic benefits.

EPA supplementation (1-3 g/day) improves symptoms in various psychiatric disorders including depression, bipolar disorder, and schizophrenia, whereas DHA alone shows no effect on depression in tested trials.

If you are managing a psychiatric condition, discuss EPA supplementation (1-3g/day) with your doctor. The evidence suggests EPA is effective for mood disorders, whereas DHA alone has not shown similar benefits for depression. Note that very high doses of EPA (>=4g/day) may be less effective than moderate doses.

Excessive fructose consumption promotes nonalcoholic fatty liver disease (NAFLD) by acting as both a substrate and an inducer of hepatic de novo lipogenesis (DNL), leading to lipid accumulation and subsequent oxidative stress and inflammation.

Limit intake of added fructose, particularly from sugar-sweetened beverages and processed foods, as it directly drives liver fat accumulation and inflammation. Focus on whole foods where fructose is accompanied by fiber.

Fructose consumption negatively impacts peripheral tissues (gut, muscle, adipose) through interorgan cross-talk, leading to gut dysbiosis, visceral adiposity, and muscle insulin resistance/sarcopenia.

High fructose intake doesn't just hurt the liver; it can worsen gut health, increase belly fat, and reduce muscle insulin sensitivity. Reducing fructose supports whole-body metabolic health.

Population-wide reduction of average sodium intake from 9.5 g/d to 6 g/d through industry reformulation and public awareness campaigns significantly lowers average blood pressure, thereby reducing the incidence of cardiovascular disease and stroke.

To improve your heart health, aim to reduce your daily salt intake to 6 grams. You can do this by choosing foods with lower salt content, checking front-of-pack labels for traffic light indicators, and gradually reducing added salt in cooking to allow your taste buds to adapt over 8 weeks.

Rapid weight loss followed by sustained weight maintenance significantly increases free testosterone and sex hormone-binding globulin (SHBG) levels in abdominally obese men with metabolic syndrome, reducing the prevalence of biochemical hypogonadism.

For obese men with metabolic syndrome, achieving significant weight loss and keeping it off is a powerful way to restore healthy testosterone levels. This study used a very low-calorie diet (800 kcal) for 9 weeks, followed by a moderate low-fat diet (1200 kcal) for a year. The key takeaway is that the hormonal benefits, specifically increased free testosterone and SHBG, are sustained even after transitioning to a less restrictive maintenance diet, provided the weight is kept off.

Short-term high-dose testosterone therapy in older men improves body composition (increasing lean mass and decreasing fat mass) without altering upper airway dimensions or causing detectable changes in physical, mental, or metabolic function.

High-dose testosterone can increase muscle mass and reduce fat in older men, but this short-term change does not necessarily translate to better physical performance, mood, or metabolic health. You may see changes on the scale or in measurements, but not necessarily in how you feel or function day-to-day.

Moderate weight reduction (approx. 6% BMI decrease) shifts adiponectin oligomer composition toward high molecular weight (HMW) and medium molecular weight (MMW) forms, which are strongly correlated with increased HDL cholesterol.

If you are losing weight moderately (about 6% of body weight) through a balanced diet and moderate exercise, your body produces more of the 'high molecular weight' form of adiponectin. This specific form is linked to better HDL (good) cholesterol levels. You don't need extreme weight loss to see these specific hormonal benefits; a steady, moderate reduction is effective at shifting your adiponectin profile to support heart health.